Works matching IS 15233790 AND DT 2014 AND VI 16 AND IP 2

Results: 7

Etirinotecan Pegol: Development of a Novel Conjugated Topoisomerase I Inhibitor.

Published in:

Current Oncology Reports, 2014, v. 16, n. 2, p. 1, doi. 10.1007/s11912-013-0367-8

By:

Alemany, Carlos

Publication type:

Article

Endoglin for Targeted Cancer Treatment.

Published in:

Current Oncology Reports, 2014, v. 16, n. 2, p. 1, doi. 10.1007/s11912-013-0365-x

By:

Rosen, Lee;
Gordon, Michael;
Robert, Francisco;
Matei, Daniela

Publication type:

Article

Timing of Determining Axillary Lymph Node Status When Neoadjuvant Chemotherapy is Used.

Published in:

Current Oncology Reports, 2014, v. 16, n. 2, p. 1, doi. 10.1007/s11912-013-0364-y

By:

Mamounas, Eleftherios

Publication type:

Article

Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin.

Published in:

Current Oncology Reports, 2014, v. 16, n. 2, p. 1, doi. 10.1007/s11912-013-0370-0

By:

Eisen, Tim;
Hedlund, Gunnar;
Forsberg, Göran;
Hawkins, Robert

Publication type:

Article

Aflibercept-a Decoy VEGF Receptor.

Published in:

Current Oncology Reports, 2014, v. 16, n. 2, p. 1, doi. 10.1007/s11912-013-0368-7

By:

Ciombor, Kristen;
Berlin, Jordan

Publication type:

Article

Endoscopic Resection of Sinonasal Cancers.

Published in:

Current Oncology Reports, 2014, v. 16, n. 2, p. 1, doi. 10.1007/s11912-013-0369-6

By:

Su, Shirley;
Kupferman, Michael;
DeMonte, Franco;
Levine, Nicholas;
Raza, Shaan;
Hanna, Ehab

Publication type:

Article

Resectable, Borderline Resectable, and Locally Advanced Pancreatic Cancer: What Does It Matter?

Published in:

Current Oncology Reports, 2014, v. 16, n. 2, p. 1, doi. 10.1007/s11912-013-0366-9

By:

Halperin, Daniel;
Varadhachary, Gauri

Publication type:

Article